Secondly, the known AAA-1 associations with higher CV risk [16, 49, 50] were also reproduced, as well as the fact that NAFLD individuals (FLI > 60) had higher AST/ALT enzyme levels compared to non-NAFLD individuals. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.